	US 12,257,258 B2
	Tryptamine compositions for enhancing neurite outgrowth
Paul Edward Stamets, Shelton, WA (US)
Assigned to TURTLE BEAR HOLDINGS, LLC, Shelton, WA (US)
Filed by TURTLE BEAR HOLDINGS, LLC, Shelton, WA (US)
Filed on Sep. 27, 2023, as Appl. No. 18/475,724.
Application 18/475,724 is a continuation of application No. 17/570,054, filed on Jan. 6, 2022, granted, now 11,911,401.
Application 17/570,054 is a continuation of application No. 16/951,009, filed on Nov. 18, 2020, granted, now 11,660,305, issued on May 30, 2023.
Claims priority of provisional application 63/007,482, filed on Apr. 9, 2020.
Claims priority of provisional application 62/937,536, filed on Nov. 19, 2019.
Prior Publication US 2024/0108640 A1, Apr. 4, 2024
Int. Cl. A61K 31/661 (2006.01); A61K 9/08 (2006.01); A61K 31/05 (2006.01); A61K 31/352 (2006.01); A61K 31/4045 (2006.01); A61K 31/455 (2006.01); A61K 36/06 (2006.01); A61K 36/066 (2006.01); A61K 36/07 (2006.01); A61K 36/185 (2006.01); A61K 36/73 (2006.01); A61P 25/24 (2006.01)

CPC A61K 31/661 (2013.01) [A61K 9/08 (2013.01); A61K 31/05 (2013.01); A61K 31/352 (2013.01); A61K 31/4045 (2013.01); A61K 31/455 (2013.01); A61K 36/06 (2013.01); A61K 36/066 (2013.01); A61K 36/07 (2013.01); A61K 36/185 (2013.01); A61K 36/73 (2013.01); A61P 25/24 (2018.01)]

21 Claims

1. A pharmaceutical composition comprising:

0.1 mg to 10 mg of psilocin, psilocybin, salts thereof, or combinations thereof; and

one or more pharmaceutically acceptable excipients selected from carriers, fillers, binders, disintegrants, preservatives, or antioxidants.